Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

Deutsche Bank downgraded Informatica (INFA) to Hold from Buy with a $21 price target The firm cites the company’s “disappointing” Q4 results ...

Deutsche Bank, Germany’s largest financial institution, has partnered with Swiss crypto company Taurus and launched a ...

MUMBAI: Shriram Finance, the largest non-bank lender in terms of loan book and the flagship of the Chennai-based Shriram ...

Germany's Commerzbank will cut thousands of jobs as the bank battles to fend off a takeover bid from Italian banking giant ...

Debt sale received a BBB rating from S&P because it expects Flower Foods’ net debt–to–EBITDA ratio to remain above 3 for at least two years.

Good afternoon, ladies and gentlemen, and welcome to the Deutsche Börse AG Analyst and Investor Conference Call regarding the Q4 and Full Year 2024 preliminary financial results. At this time, all ...

Germany's Commerzbank is considering slashing thousands of jobs as the bank battles to fend off a takeover bid from Italian ...

(Reuters) - CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that ...

M&A markets don't like volatility and unpredictability, and what we've seen in the past few weeks is the opposite of that,” ...

Deutsche Bank (ETR:DBKGn) initiated coverage of Sarepta Therapeutics (NASDAQ:SRPT), assigning a Hold rating to the ...